Tarsus Pharmaceuticals Inc (TARS)
Healthcare
Biotechnology
59.00 $
-0.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Tarsus Pharmaceuticals Inc (TARS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -1.2 | -3.7 | -21 | 3.7 | -49 | -117 | -83 | -12 | |
| 0.0 | 0.0 | 0.1 | 0.3 | 0.3 | 0.9 | 1.2 | 1.8 | |
| 0.0 | 0.0 | 0.8 | 8.5 | 13 | 20 | 28 | 42 | |
| 0.0 | 0.4 | 4.0 | 15 | 14 | – | – | – | |
| 0.1 | 0.5 | 1.5 | 1.4 | -1.0 | 0.3 | 3.8 | 15 | |
| 0.0 | 0.2 | 0.5 | 0.6 | 0.5 | 5.5 | 1.6 | 9.9 | |
| 0.0 | -0.2 | -0.5 | -0.6 | -145 | 141 | -199 | -42 | |
| – | – | 0.0 | 0.3 | 75 | – | – | – | |
| 2.0 | 2.0 | 20 | 20 | -0.9 | 10 | 75 | 0.0 | |
| 3.6 | 59 | 132 | 0.0 | 94 | 130 | 155 | 143 | |
| 2.4 | 56 | 110 | 3.2 | -100 | 153 | -128 | 89 | |
| -1.2 | -3.8 | -22 | 3.2 | -50 | -123 | -85 | -22 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.